Sandip Sabharwal on what’s driving pharma and why Delta stock is unbuyable

The Indian government’s proposed tax on the casino industry makes Delta Corp an unviable stock, says Sandip Sabharwal. However, pharma stocks are currently doing well due to a combination of factors, including global price upticks on generics and decent domestic sales. In the auto pack, the growth of sedans is slowing down while SUVs are selling more, but this is not as good news as it appears. Record-high premium property sales are testament to the country’s growing economy.